ARCHIVES

Senate approves $1 billion increase for NIH; 3.7% raise is smallest since 1995.

This article is from The Cancer Letter archive.

Vol. 29 No. 34 | September 19, 2003

Download PDF Visit The Full Archive

Related Articles

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists.

June 4, 2004

Niccotine Reports As Aiding Metastasis

August 22, 1986

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999

Low-Income Women Lack Mammography Access: Survey

May 14, 1993